National Research (NRC) Stock Price, News & Analysis

Company Overview

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Key Stats

• Today's Range: $11.51 to $12.48
• 50-Day Range: $11.92 to $18.73
• 52-Week Range: $11.38 to $37.75
• Volume: 120,439 shs
• Average Volume: 91,086 shs
• Market Capitalization: $284.53 million
• P/E Ratio: 11.81
• Dividend Yield: 3.87%
• Price Target: N/A
• Consensus Rating: N/A

NRC Stock Analysis - Frequently Asked Questions

How have NRC shares performed this year?

National Research's stock was trading at $17.64 at the beginning of 2025. Since then, NRC stock has decreased by 29.7% and is now trading at $12.40.
View the best growth stocks for 2025 here.

How were National Research's earnings last quarter?

National Research Co. (NASDAQ:NRC) issued its earnings results on Monday, January, 27th. The company reported $0.28 EPS for the quarter. National Research had a trailing twelve-month return on equity of 66.52% and a net margin of 17.32%.

Does National Research have any subsidiaries?

The following companies are subsidiaries of National Research: PatientWisdom Inc., The Governance Institute, and National Research Corporation Canada.

How do I buy shares of National Research?

Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of National Research own?

Based on aggregate information from My MarketBeat watchlists, some other companies that National Research investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Alphabet (GOOG), Netflix (NFLX), Advanced Micro Devices (AMD) and JPMorgan Chase & Co. (JPM).

Company Calendar

• Record date for 1/10 Dividend: 12/27/2024
• Ex-Dividend for 1/10 Dividend: 12/27/2024
• Dividend Payable: 1/10/2025
• Last Earnings: 1/27/2025
• Record date for 4/11 Dividend: 3/28/2025
• Ex-Dividend for 4/11 Dividend: 3/28/2025
• Today: 4/04/2025
• Dividend Payable: 4/11/2025
• Next Earnings (Estimated): 5/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Commercial physical research
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:NRC
• CIK: 70487
• Web: www.nrchealth.com
• Phone: (402) 475-2525
• Fax: 402-475-9061
• Employees: 490
• Year Founded: 1981

Profitability

• EPS (Most Recent Fiscal Year): $1.05
• Trailing P/E Ratio: 11.59
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $24.78 million
• Net Margins: 17.32%
• Pretax Margin: 24.48%
• Return on Equity: 66.52%
• Return on Assets: 20.00%

Debt

• Debt-to-Equity Ratio: 1.30
• Current Ratio: 0.47
• Quick Ratio: 0.47

Sales & Book Value

• Annual Sales: $143.06 million
• Price / Sales: 1.97
• Cash Flow: $1.13 per share
• Price / Cash Flow: 10.81
• Book Value: $2.02 per share
• Price / Book: 6.07

Miscellaneous

• Outstanding Shares: 22,946,000
• Free Float: 23,006,000
• Market Cap: $281.25 million
• Optionable: Optionable
• Beta: 0.41